ElectroSonix™ licenses University of Arizona patents for acoustoelectric imaging
ElectroSonix™ selected as finalist of 2019 Venture Madness Conference
ElectroSonix has licensed the University of Arizona patents for acoustoelectric imaging, a technology that has the potential to improve the accuracy of cardiac ablation procedures in treating cardiac arrhythmias.
Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the University of Arizona, has been licensed to startup ElectroSonix.
January 24, 2019
ElectroSonix is proud and honored to have been selected as finalists of the 2019 Venture Madness Conference and competition.
Thirty four companies are given the opportunity to present for a chance to earn cash prizes, access to investors, recognition and the coveted title of Venture Madness Champion. ElectroSonix will compete under the Healthcare category.
More information can be found in the following websites:
Invest Southwest unveils Venture Madness finalists - AZ Big Media
NIH SBIR PHASE I AWARD
September 21, 2018
ElectroSonix is awarded a National Institutes of Health (NIH) SBIR Phase I grant in the amount of $224,560 to ElectroSonix, LC to develop 4D Acoustoelectric Cardiac Imaging for Fast and Accurate Mapping of Arrhythmias.